Aha1 Is an Autonomous Chaperone for SULT1A1

Little is known about the specific client proteins of the cochaperone Aha1. Prior research has shown that Aha1 activates HSP90 ATPase, aiding in the folding of various proteins. However, the direct targets of Aha1 remain unclear. SULT1A1 is a phase-II enzyme involved in detoxification, but its regulation mechanisms are not fully understood. No prior work had resolved whether Aha1 functions independently of HSP90 in this context. This gap motivated the current investigation into Aha1's role in SULT1A1 regulation. The study aimed to clarify if Aha1 acts autonomously or in conjunction with HSP90. Understanding this could provide insights into detoxification pathways and enzyme stability. The findings may contribute to broader knowledge of chaperone-client interactions.

This study aimed to determine if Aha1 regulates SULT1A1 independently of HSP90. The researchers wanted to identify whether Aha1 functions as an autonomous chaperone for SULT1A1. They focused on the interaction between Aha1 and SULT1A1 using proximity labeling and immunoprecipitation techniques. The motivation stemmed from the lack of known Aha1 client proteins and the unclear role of Aha1 in SULT1A1 regulation. The team sought to clarify if Aha1 modulates SULT1A1 protein levels without HSP90 involvement. They also aimed to test the functional consequences of Aha1 depletion. The study's outcomes could inform future research on chaperone mechanisms. This work may help refine models of enzyme maturation and stability.

The researchers used an APEX-based proximity labeling method to identify SULT1A1 as a HSP90-associated protein. They performed genetic depletion of Aha1 and assessed SULT1A1 levels. Immunoprecipitation followed by Western blot confirmed the Aha1-SULT1A1 interaction. Pharmacological inhibition of HSP90 was used to distinguish Aha1-specific effects. A maturation-dependent interaction assay tested Aha1 and HSP90 binding to SULT1A1. Reconstitution experiments used wild-type and mutant Aha1 to assess functional rescue. The E67K mutant, which does not bind HSP90, was tested for SULT1A1 restoration. An Aha1 mutant lacking the first 20 amino acids was used to evaluate autonomous chaperone function.

Genetic depletion of Aha1 reduced SULT1A1 protein levels, but not with HSP90 inhibition. Immunoprecipitation showed Aha1 interacts with SULT1A1, not HSP90. A maturation assay revealed Aha1 binds preferentially to newly synthesized SULT1A1. Reconstitution with wild-type Aha1 or the E67K mutant restored SULT1A1 levels equally. The Aha1 mutant lacking the first 20 amino acids failed to rescue SULT1A1 levels. These findings suggest Aha1 regulates SULT1A1 independently of HSP90. The E67K mutant's success implies HSP90 interaction is not essential for SULT1A1 regulation. The amino acid deletion mutant's failure highlights the importance of Aha1's autonomous function.

The study demonstrated that Aha1 functions as an autonomous chaperone for SULT1A1. The findings suggest Aha1 regulates SULT1A1 protein levels without HSP90 involvement. The E67K mutant's ability to restore SULT1A1 levels supports this conclusion. The amino acid deletion mutant's failure confirms the role of Aha1's autonomous function. The results indicate that Aha1's interaction with HSP90 is not necessary for SULT1A1 regulation. The study provides the first evidence of Aha1 acting independently in this context. These findings may influence future research on chaperone mechanisms. The work suggests Aha1's role in modulating detoxification pathways.